Skip to main content

Advertisement

Log in

MRI-detected bone marrow edema in early rheumatoid arthritis

  • Clinical Advance
  • Published:

From Nature Clinical Practice Rheumatology

View current issue Sign up to alerts

Abstract

The availability of therapeutics, such as biologics targeting TNF, has enabled marked inhibition of structural damage previously thought to be unavoidable in many patients with rheumatoid arthritis (RA). The importance of physicians being able to reliably identify patients at the greatest risk of disease progression is, therefore, increasing. Many prognostic markers, including MRI-detected pathology at the wrist, have been known for some time to correlate with radiographic RA disease progression on a cohort basis. In a substudy of a clinical trial of two conventional DMARD regimens in a cohort of early RA patients, Hetland et al. explored the relationships between the progression of radiographic erosions and the pathological features identifiable on MRI at baseline, as well as several other putative prognostic markers. Here I discuss the potential implications of this study's findings in understanding the role of bone marrow inflammation in tissue destructive pathways.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. McQueen FM et al. (2003) Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis. Arthritis Rheum 48: 1814–1827

    Article  Google Scholar 

  2. Dohn UM et al. (2007) Rheumatoid arthritis bone erosion volumes on CT and MRI: reliability and correlations with erosion scores on CT, MRI and radiography. Ann Rheum Dis 66: 1388–1392

    Article  Google Scholar 

  3. Hetland ML et al. (2008) MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2 year randomized controlled trial (CIMESTRA). Ann Rheum Dis [doi:10.1136/ard.2008.088245]

  4. Hakala M et al. (2008) Combination drug strategy in recent-onset rheumatoid arthritis suppresses collagen I degradation and is associated with retardation of radiological progression. Scand J Rheumatol 37: 90–93

    Article  CAS  Google Scholar 

  5. Landewé R et al. (2004) Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis. Arthritis Rheum 50: 1390–1399

    Article  Google Scholar 

  6. Haavardsholm EA et al. (2008) Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression. Ann Rheum Dis 67: 794–800

    Article  CAS  Google Scholar 

  7. Jimenez-Boj E et al. (2007) Bone erosions and bone marrow oedema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis. Arthritis Rheum 56: 1118–1124

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taylor, P. MRI-detected bone marrow edema in early rheumatoid arthritis. Nat Rev Rheumatol 4, 516–517 (2008). https://doi.org/10.1038/ncprheum0897

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0897

  • Springer Nature Limited

Navigation